Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Active· Submitted in House
Introduced
Oct 10, 25
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Oct 10, 25
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Action Timeline
2
OCT 10, 2025•House floor actions
Referred to the House Committee on Energy and Commerce.